Antiserum against tumor necrosis factor-alpha and a protease inhibitor reduce immune glomerular injury
- 1 July 1991
- journal article
- Published by Elsevier in Kidney International
- Vol. 40 (1) , 43-51
- https://doi.org/10.1038/ki.1991.177
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5).The Journal of Experimental Medicine, 1988
- Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.The Journal of Experimental Medicine, 1987
- Protection from tumor necrosis factor cytotoxicity by protease inhibitorsCellular Immunology, 1987
- Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritisKidney International, 1987
- New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system.Journal of Clinical Investigation, 1987
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985
- Glomerular Basement Membrane Injury by Neutrophil and Monocyte Neutral ProteinasesKidney and Blood Pressure Research, 1980
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978